Pathophysiology and treatment of myoclonus.

[1]  S Mohammadi,et al.  Nerve fiber impairment of anterior thalamocortical circuitry in juvenile myoclonic epilepsy , 2008, Neurology.

[2]  Í. Lopes-Cendes,et al.  Characterization of the C-terminal half of human juvenile myoclonic epilepsy protein EFHC1: dimer formation blocks Ca2+ and Mg2+ binding to its functional EF-hand. , 2008, Archives of biochemistry and biophysics.

[3]  G. Collingridge,et al.  Mechanisms Involved in the Reduction of GABAA Receptor α1-Subunit Expression Caused by the Epilepsy Mutation A322D in the Trafficking-competent Receptor* , 2008, Journal of Biological Chemistry.

[4]  A. Durr,et al.  Myoclonus–dystonia , 2008, Neurology.

[5]  R. Bhidayasiri,et al.  Post-hypoxic animal model of myoclonus. , 2007, Parkinsonism & related disorders.

[6]  J. Valls-Solé.  Electrodiagnostic studies of the facial nerve in peripheral facial palsy and hemifacial spasm , 2007, Muscle & nerve.

[7]  Yuqing Li,et al.  Myoclonus, Motor Deficits, Alterations in Emotional Responses and Monoamine Metabolism in ε-Sarcoglycan Deficient Mice , 2006 .

[8]  E. Louis,et al.  A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor , 2005, Neurology.

[9]  I. Regidor,et al.  Pallidal stimulation relieves myoclonus–dystonia syndrome , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  P. Hof,et al.  ϵ‐Sarcoglycan immunoreactivity and mRNA expression in mouse brain , 2005 .

[11]  J. Caviness,et al.  Myoclonus: current concepts and recent advances , 2004, The Lancet Neurology.

[12]  C. Adler,et al.  Abnormal corticomuscular coherence is associated with the small amplitude cortical myoclonus in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[13]  C. Cremers,et al.  Treatment for severe palatoclonus by occlusion of the eustachian tube. , 2003, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[14]  S. Fahn,et al.  A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus , 2001, Neurology.

[15]  F. Dubeau,et al.  Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy. , 2001, Archives of neurology.

[16]  P. Genton,et al.  Antimyoclonic effect of levetiracetam. , 2000, Epileptic disorders : international epilepsy journal with videotape.

[17]  R. Sheth,et al.  Intravenous valproic acid for myoclonic status epilepticus , 2000, Neurology.

[18]  M. Hallett,et al.  Electrophysiological studies of myoclonus , 2000, Muscle & nerve.

[19]  D. Maraganore,et al.  The incidence and prevalence of myoclonus in Olmsted County, Minnesota. , 1999, Mayo Clinic proceedings.

[20]  J. R. Rosenberg,et al.  Coherent cortical and muscle discharge in cortical myoclonus. , 1999, Brain : a journal of neurology.

[21]  P. Burbaud,et al.  Stimulus‐sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A , 1999, Movement disorders : official journal of the Movement Disorder Society.

[22]  A. Mínguez-Castellanos,et al.  Myoclonus associated with thoracodorsal neuropathy , 1998, Movement disorders : official journal of the Movement Disorder Society.

[23]  M. Morrison,et al.  Botulinum toxin treatment of essential palatal myoclonus tinnitus. , 1998, The Journal of otolaryngology.

[24]  T. Mima,et al.  Pathogenesis of cortical myoclonus studied by magnetoencephalography , 1998, Annals of neurology.

[25]  T. Mima,et al.  Cortical myoclonus , 1998, Neurology.

[26]  S. Lamusuo,et al.  Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo , 1998, Journal of neurology, neurosurgery, and psychiatry.

[27]  S. Wallace.  Myoclonus and epilepsy in childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide , 1998, Epilepsy Research.

[28]  E. Ben-Menachem,et al.  Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients , 1998, Epilepsy Research.

[29]  J. Caviness,et al.  Cortical myoclonus in huntington's disease associated with an enlarged somatosensory evoked potential , 1997, Movement disorders : official journal of the Movement Disorder Society.

[30]  R. Mutani.  Focal subcortical reflex myoclonus , 1997 .

[31]  R. Mutani,et al.  Focal subcortical reflex myoclonus. A clinical and neurophysiological study. , 1997, Archives of neurology.

[32]  A. Oliviero,et al.  Changes in spinal cord excitability in a patient with rhythmic segmental myoclonus. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[33]  H. Shibasaki,et al.  Clinical trial of piracetam in patients with myoclonus: Nationwide multiinstitution study in Japan , 1996, Movement disorders : official journal of the Movement Disorder Society.

[34]  I. Kanazawa,et al.  Magnetoencephalographic analysis of cortical myoclonic jerks. , 1996, Electroencephalography and clinical neurophysiology.

[35]  N. Buchanan,et al.  The use of lamotrigine in juvenile myoclonic epilepsy , 1996, Seizure.

[36]  M. Pless,et al.  Treatment of opsoclonus-myoclonus with highdose intravenous immunoglobulin , 1996, Neurology.

[37]  O. Snead,et al.  Basic mechanisms of generalized absence seizures , 1995, Annals of neurology.

[38]  J. Caviness,et al.  The movement disorders of adult opsoclonus , 1995, Movement disorders : official journal of the Movement Disorder Society.

[39]  M. Hallett,et al.  Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. , 1994, Brain : a journal of neurology.

[40]  I Savic,et al.  In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[41]  C. Marsden,et al.  Axial myoclonus of propriospinal origin. , 1991, Brain : a journal of neurology.

[42]  G. Deuschl,et al.  Symptomatic and essential rhythmic palatal myoclonus. , 1990, Brain : a journal of neurology.

[43]  H Shibasaki,et al.  Cortical tremor , 1990, Neurology.

[44]  P. Thompson,et al.  The treatment of severe action myoclonus. , 1989, Brain : a journal of neurology.

[45]  J. Jankovic,et al.  Segmental myoclonus. Clinical and pharmacologic study. , 1986, Archives of neurology.

[46]  F. Sharbrough,et al.  Brainstem auditory evoked potentials in 20 patients with palatal myoclonus. , 1983, Archives of neurology.

[47]  N. Murray,et al.  Stimulus-sensitive spinal myoclonus. , 1981, Journal of neurology, neurosurgery, and psychiatry.

[48]  M. Hallett,et al.  Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[49]  T. Welty.  Juvenile Myoclonic Epilepsy , 2006, Paediatric drugs.

[50]  P. Brown.  Clinical neurophysiology of myoclonus , 2006 .

[51]  F. Mauguière,et al.  Handbook of clinical neurophysiology , 2003 .

[52]  H. Shibasaki,et al.  Spinal myoclonus resembling belly dance , 1994, Movement disorders : official journal of the Movement Disorder Society.

[53]  P. Thompson,et al.  Effectiveness of piracetam in cortical myoclonus , 1993, Movement disorders : official journal of the Movement Disorder Society.

[54]  Richardson Jc,et al.  Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. , 1986 .

[55]  M. Baulac,et al.  Postmortem studies on posthypoxic and post-methyl bromide intoxication: case reports. , 1986, Advances in neurology.

[56]  M. Hallett,et al.  The nosology and pathophysiology of myoclonus , 1981 .

[57]  S. Fahn.  Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen. , 1979, Advances in neurology.